Acetylcholinesterase and butyrylcholinesterase as markers of low-grade systemic inflammation
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 3
Abstract
Authors and Affiliations
Undurti Das
Keywords
Related Articles
- EP ID EP78156
- DOI -
- Views 119
- Downloads 0
Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture
Introduction. Sirolimus has inhibitory effects on epithelial healing and cholangiocyte regeneration. In liver transplantation (LT) patients, these effects may be greatest at the biliary anastomosis. We therefore investig...
Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis
Background. Bacterial infections are frequent complications in patients with cirrhosis. Since they are associated with poor outcomes, antibiotics are frequently over-prescribed. Surrogate markers of bacterial infections,...
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment
Introduction. Host lipid metabolism influences viral replication and lifecycle of hepatitis C virus. Our aim was to evaluate changes in glucose and lipid metabolism of patients with chronic hepatitis C after therapy with...
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries, and its prevalence is increasing worldwide. It currently affects approximately 30% of adults and 10% of children an...
Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients
Non-alcoholic fatty liver disease (NAFLD) is defined as a spectrum of liver diseases ranging from simple steatosis to steatohepatitis (NASH). Alterations in intestinal microbiota and inflammatory response may play a key...